Omnicell (OMCL) Competitors $45.67 -0.93 (-2.00%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends OMCL vs. FIT, MDRX, HSTM, HMI, CRTX, OSS, ZEPP, SCKT, CERN, and AAPLShould you be buying Omnicell stock or one of its competitors? The main competitors of Omnicell include Fitbit (FIT), Veradigm (MDRX), HealthStream (HSTM), Huami (HMI), Cortexyme (CRTX), One Stop Systems (OSS), Zepp Health (ZEPP), Socket Mobile (SCKT), Cerner (CERN), and Apple (AAPL). Omnicell vs. Fitbit Veradigm HealthStream Huami Cortexyme One Stop Systems Zepp Health Socket Mobile Cerner Apple Omnicell (NASDAQ:OMCL) and Fitbit (NYSE:FIT) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation, profitability and community ranking. Does the media refer more to OMCL or FIT? In the previous week, Fitbit had 1 more articles in the media than Omnicell. MarketBeat recorded 5 mentions for Fitbit and 4 mentions for Omnicell. Omnicell's average media sentiment score of 1.36 beat Fitbit's score of 0.00 indicating that Omnicell is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omnicell 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fitbit 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Is OMCL or FIT more profitable? Fitbit has a net margin of 0.00% compared to Omnicell's net margin of -1.66%. Omnicell's return on equity of 2.55% beat Fitbit's return on equity.Company Net Margins Return on Equity Return on Assets Omnicell-1.66% 2.55% 1.35% Fitbit N/A N/A N/A Which has better earnings & valuation, OMCL or FIT? Omnicell has higher earnings, but lower revenue than Fitbit. Omnicell is trading at a lower price-to-earnings ratio than Fitbit, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOmnicell$1.15B1.84-$20.37M-$0.39-117.10Fitbit$1.43B1.18-$320.71M-$0.98-7.07 Do insiders and institutionals hold more shares of OMCL or FIT? 97.7% of Omnicell shares are held by institutional investors. 2.6% of Omnicell shares are held by insiders. Comparatively, 18.6% of Fitbit shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts recommend OMCL or FIT? Omnicell currently has a consensus target price of $50.83, indicating a potential upside of 11.31%. Given Omnicell's stronger consensus rating and higher probable upside, equities research analysts plainly believe Omnicell is more favorable than Fitbit.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Omnicell 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33Fitbit 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in OMCL or FIT? Fitbit received 290 more outperform votes than Omnicell when rated by MarketBeat users. However, 67.34% of users gave Omnicell an outperform vote while only 66.75% of users gave Fitbit an outperform vote. CompanyUnderperformOutperformOmnicellOutperform Votes49967.34% Underperform Votes24232.66% FitbitOutperform Votes78966.75% Underperform Votes39333.25% SummaryOmnicell beats Fitbit on 11 of the 17 factors compared between the two stocks. Ad WealthPressThe Tesla Trade Is Back In BusinessIf you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. Get Omnicell News Delivered to You Automatically Sign up to receive the latest news and ratings for OMCL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OMCL vs. The Competition Export to ExcelMetricOmnicellElectronic computers IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.12B$439.79B$5.15B$8.74BDividend YieldN/A1.13%5.18%4.08%P/E Ratio-117.1014.0166.3713.55Price / Sales1.843.171,276.8487.67Price / Cash14.5323.1839.7035.24Price / Book1.7210.676.475.93Net Income-$20.37M$12.30B$119.73M$225.73M7 Day Performance-8.92%-3.57%-5.13%-1.34%1 Month Performance10.23%-6.80%-2.71%1.15%1 Year Performance37.93%15.38%31.08%24.02% Omnicell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMCLOmnicell3.3892 of 5 stars$45.67-2.0%$50.83+11.3%+36.4%$2.12B$1.15B-117.103,650Analyst DowngradeAnalyst RevisionPositive NewsFITFitbitN/A$6.93flatN/A+0.0%$1.70B$1.43B-7.071,684High Trading VolumeMDRXVeradigm2.0644 of 5 stars$9.60+1.1%N/A-15.7%$1.03B$1.50B0.008,000Analyst ForecastNews CoverageGap UpHSTMHealthStream4.4336 of 5 stars$32.24+1.4%N/A+24.1%$980.74M$279.06M49.601,092Positive NewsHMIHuamiN/AN/AN/AN/A$484.19M$834.88M11.131,132CRTXCortexymeN/A$1.95+2.6%N/A+99.0%$58.79MN/A-0.6655Gap UpOSSOne Stop Systems3.1313 of 5 stars$2.67+12.2%N/A+12.7%$56.36M$60.90M-5.34110Gap DownZEPPZepp Health2.286 of 5 stars$3.27+1.9%N/A-35.6%$49.22M$245.88M-1.991,230Upcoming EarningsNews CoverageGap DownSCKTSocket Mobile2.4134 of 5 stars$1.18flatN/A+17.4%$8.97M$17.03M-5.3650Short Interest ↓Gap DownCERNCerner2.9739 of 5 stars$94.92flatN/A+0.0%$27.92B$5.76B47.7025,150Analyst ForecastAAPLApple4.8363 of 5 stars$226.96-0.2%N/A+18.6%$3.43T$391.04B37.33161,000Analyst ForecastShort Interest ↓Positive News Related Companies and Tools Related Companies Fitbit Competitors Veradigm Competitors HealthStream Competitors Huami Competitors Cortexyme Competitors One Stop Systems Competitors Zepp Health Competitors Socket Mobile Competitors Cerner Competitors Apple Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OMCL) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omnicell, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omnicell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
